You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 7, July 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (42)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gadolinium—Pentetic Acid Magnetic Resonance Imaging in Patients With Relapsing Remitting Multiple Sclerosis

Ruggero Capra, MD; Nicoletta Marcianò, MD; Luigi A. Vignolo, MD; Antonio Chiesa, MD; Roberto Gasparotti, MD

Arch Neurol. 1992;49(7):687-689.


Abstract

• Ten patients with relapsing-remitting multiple sclerosis have been studied by serial gadolinium—pentetic acid magnetic resonance imaging (MRI) every 14 days for 3 months. At the end of the follow-up, seven relapses occurred in six patients; no therapy was administered during the study. Ninety-three enhancing lesions were collected in eight patients. With regard to the duration of the enhancement, 32 lesions were detected in only one MRI scan and 32 were found in more MRI scans (most of the lesions occurring in two serial examinations). Four old lesions increased their size with delayed enhancement. Correlation was found between the relapses and the gadolinium—pentetic acid—enhancing areas only for one brain-stem and two cervical spinal cord lesions. Gadolinium—pentetic acid MRI provides useful information about activity of the disease that cannot be obtained clinically even if the dynamic of the lesions may be undervalued in old plaques.



Author Affiliations

From the Departments of Neurology (Drs Capra, Marcianò, and Vignolo) and Radiology (Drs Chiesa and Gasparotti), University of Medicine, Brescia, Italy.


Footnotes

Accepted for publication October 21, 1991.

Reprint requests to 2a Neurologia, Universitá Deli Studi diBrescia, Piazza Spedali Civili 1, 25123 Brescia, Italia (Dr Capra).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals
Cotton et al.
Neurology 2003;60:640-646.
ABSTRACT | FULL TEXT  

Differences between Relapsing-Remitting and Chronic Progressive Multiple Sclerosis as Determined with Quantitative MR Imaging
Miki et al.
Radiology 1999;210:769-774.
ABSTRACT | FULL TEXT  

Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis
Edwards et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:736-741.
ABSTRACT | FULL TEXT  

The Use of Brain Magnetic Resonance Imaging in Multiple Sclerosis
Goodkin et al.
Arch Neurol 1994;51:505-516.
ABSTRACT  

The Effect of Repositioning Error on Serial Magnetic Resonance Imaging Scans-Reply
Capra et al.
Arch Neurol 1993;50:570-571.
ABSTRACT  

The Effect of Repositioning Error on Serial Magnetic Resonance Imaging Scans
Goodkin et al.
Arch Neurol 1993;50:569-570.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.